Background It is not clear if all Americans have benefitted equally from the availability of
chimeric antigen receptor T‐cell (CART) therapy. We aimed to evaluate if demographic …

Abstract Background The US–Mexico border is a medically underserved region where
survival disparities have been observed in adults diagnosed and treated for various …

Background Breast cancer (BC) affects racial and ethnic groups differently, leading to
disparities in clinical presentation and outcomes. It is unclear how Hispanic ethnicity affects …

Background: Outcomes of patients with newly diagnosed acute myeloid leukemia (AML)
differ based on academic affiliation and case volume. The primary objective examined the …

Background Hematopoietic stem cell transplantation (HSCT) is a pivotal treatment for high-
risk acute lymphocytic leukemia (ALL), although limited by suitable human leukocyte antigen …

Background: This present study experimentally evaluated the Pasos Para Prevenir Cancer
(PPPC) program to determine whether participation was associated with improved physical …

Cancer is a challenging, multifaceted disease that involves a combination of biological and
nonbiological factors. Aside from COVID-19, cancer is the second leading cause of death in …

Background Imatinib is the most widely used tyrosine kinase inhibitor (TKI) in patients with
newly diagnosed chronic-phase chronic myeloid leukemia (CML-CP). However, failure to …

Despite recent therapeutic advances, ethnic minorities in the US continue to have
disproportionately poor outcomes in many hematologic malignancies including AML. We …

Cancer has emerged as a significant public health problem worldwide, and trends suggest
that low-or middle-income countries (LMICs) will experience a substantial increase in cancer …